stock.name

Macrogenics Inc

MGNX

Market Cap$898.99M
Close$

Compare Macrogenics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Macrogenics IncMacrogenics Inc-99.20%-6%-0.2
marketMarket Avg58.91.29%29%-1
HealthcareHealthcare Avg66.31.31%15%-0.9
$29.00

Target Price by Analysts

99.2% upsideMacrogenics Target Price DetailsTarget Price
$-0.01

Current Fair Value

100.1% downside

Overvalued by 100.1% based on the discounted cash flow analysis.

Share Statistics

Market cap$898.99 Million
Enterprise Value$703.16 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-0.15
Beta0.0
Outstanding Shares62,560,502
Avg 30 Day Volume1,413,809

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-99.25
PEG21.58
Price to Sales-
Price to Book Ratio7.28
Enterprise Value to Revenue11.97
Enterprise Value to EBIT-4.18
Enterprise Value to Net Income-78
Total Debt to Enterprise0.05
Debt to Equity0.22

Revenue Sources

No data

ESG Score

No data

About Macrogenics Inc

CEO: Scott Koenig